Skip to main content
. Author manuscript; available in PMC: 2017 Jul 27.
Published in final edited form as: Clin Trials. 2012 Apr 30;9(3):303–313. doi: 10.1177/1740774512443593

Figure 3.

Figure 3

From top left: Underlying true dose–toxicity models for scenarios A–F with the corresponding MTD specified for a 30% DLT rate. Scenarios A and B models are PO models, scenarios C and D models violate the PO assumption, and scenarios E and F models are CR models.

MTD: DLT: dose-limiting toxicity; CR: continuation ratio; PO: proportional odds; MTD: maximum tolerated dose.